| 0.695 -0.007 (-1%) | 12-07 15:58 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 3.56  |
1-year : | 5.32 |
| Resists | First : | 3.05 |
Second : | 4.55 |
| Pivot price | 1.58 |
|||
| Supports | First : | 0.61 |
Second : | 0.5 |
| MAs | MA(5) : | 0.83 |
MA(20) : | 1.88 |
| MA(100) : | 5.78 |
MA(250) : | 16.84 |
|
| MACD | MACD : | -0.9  |
Signal : | -0.8 |
| %K %D | K(14,3) : | 1.4 |
D(3) : | 1.7 |
| RSI | RSI(14): 24.5 |
|||
| 52-week | High : | 80.95 | Low : | 0.61 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SNES ] has closed above bottom band by 22.3%. Bollinger Bands are 33.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.75 - 0.75 | 0.75 - 0.75 |
| Low: | 0.6 - 0.61 | 0.61 - 0.61 |
| Close: | 0.69 - 0.7 | 0.7 - 0.7 |
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Tue, 05 Dec 2023
IBN Announces Latest Episode of The Stock2Me Podcast featuring Joel Fruendt, President & CEO of SenesTech - Benzinga
Wed, 29 Nov 2023
SenesTech, Inc. Announces Closing of $5.0 Million Public Offering - SenesTech (NASDAQ:SNES) - Benzinga
Wed, 29 Nov 2023
SenesTech Inc (SNES) is down -66.07% in a Week, Should You Accumulate? - InvestorsObserver
Tue, 28 Nov 2023
SenesTech Inc (SNES) Down 38.71% in Premarket Trading - InvestorsObserver
Mon, 27 Nov 2023
Where Will SenesTech Inc (SNES) Stock Go Next After It Has Fallen 19.66% in a Week? - InvestorsObserver
Wed, 15 Nov 2023
SenesTech Announces Reverse Stock Split - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Specialty Chemicals
|
|
| Shares Out | 0 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 300520 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 3 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -542 % |
| Return on Assets (ttm) | -115.3 % |
| Return on Equity (ttm) | -279.6 % |
| Qtrly Rev. Growth | 44 % |
| Gross Profit (p.s.) | 380328 |
| Sales Per Share | 983607 |
| EBITDA (p.s.) | -6.56557e+006 |
| Qtrly Earnings Growth | 307.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | 0.34 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0.08 |
| Dividend | 0 |
| Forward Dividend | 10300 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|